📰 Zai Lab News
Page 25 - Zai Lab News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Zai Lab. Real-time updates on events, politics, business and more.
July 26, 2023
Worldcoin is a new cryptocurrency project that aims to provide a universal basic income (UBI) to every human being on the planet
July 24, 2023
24 Jul 2023 $32 million additional capital raised, supported by all major existing investors and new investor Kreos Capital ...
July 22, 2023
NEW YORK, July 21, 2023 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, is investigating potential claims against Xponential Fitness, Inc. (NYSE:XPOF),
July 21, 2023
Through the power of the AI Innovation Lab, FPT Smart Cloud and Home Credit Vietnam have reshaped the financial sectors customer service landscape.
July 21, 2023
Biogenysis Inc. Announces a Collaboration with Khalpey AI Lab in using ...
July 21, 2023
Handelsbanken Fonder AB increased its stake in shares of Zai Lab Limited (NASDAQ:ZLAB – Free Report) by 9.6% in the first quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 95,155 shares of the company’s stock after purchasing an additional 8,366 shares during […]
July 21, 2023
Frontline Zejula maintenance therapy decreased the risk of disease progression or death in patients with newly diagnosed ovarian cancer.
July 20, 2023
- Company to Host Conference Call and Webcast on August 8, 2023, at 8:00 a.m. ETSHANGHAI, China and CAMBRIDGE, Mass., July 20, 2023 -- Zai Lab Limited today announced that it will report financial...
July 19, 2023
The Phase 3 PRIME study demonstrates that treatment with ZEJULA significantly extends progression-free survival versus placebo and reduces the risk of disease progression or death by 55% ...
July 18, 2023
Zai Lab Ltd. (ZLAB) shares are progressing more than 5 percent on Tuesday morning trade. Yesterday, the company had reported positive data from ADHERE study of VYVGART Hytrulo in patients with chronic inflammatory demyelinating polyneuropathy.